It is well known that reduced clearance of amyloid-β plays a role in the pathophysiology of Alzheimer’s disease (AD) (Kress et al., 2014), and decreased clearance of phosphorylated tau is associated with chronic traumatic encephalopathy (Plog et al., 2015). The gene discussed is MAPT; the disease is Alzheimer disease.